Literature DB >> 23021798

The association between glutathione S-transferase T1 and M1 gene polymorphisms and cardiovascular autonomic neuropathy in Slovak adolescents with type 1 diabetes mellitus.

Jarmila Vojtková1, Peter Ďurdík, Miriam Čiljaková, Zuzana Michnová, Tomáš Turčan, Eva Babušíková.   

Abstract

Glutathione S-transferase (GST), as antioxidant enzyme, protects tissue from oxidative damage typical for many pathologic conditions as type 1 diabetes (T1D) and its chronic complications. The aim of the study was to compare the prevalence of GST T1/M1 gene polymorphisms between diabetic adolescents with (CAN+) and without (CAN-) cardiovascular autonomic neuropathy. Forty-six subjects with T1D at the age 15-19 years were enrolled. CAN was diagnosed in 19 patients (41.3%) based on standard cardiovascular tests. GST M1 null genotype was more prevalent in CAN+subjects but this was not statistically significant (OR=1.889, 0.61-6.55, p>0.05). GST T1 wild genotype nearly 5-fold increased the risk of CAN (OR=4.952, 1.13-21.739, p<0.05). Regarding genotype combination, GST T1/M1 wild/null genotype was significantly more frequent in CAN+compared to the CAN- subjects (OR=3.96, 1.024-15.302, p<0.05). No significant difference was found in any biochemical parameters between CAN+and CAN- subgroups. Multivariable logistic regression showed that none of the biochemical parameters estimated was considered a risk factor for CAN, however GST T1 wild and GST T1/M1 wild/null represented a risk factor for CAN development (OR=2.227, 1.079-4.587, p<0.05 and OR=1.990, 1.026-3.859, p<0.05, respectively). GST T1 wild allele and GST T1/M1 wild/null genotype can be considered as risk factors for CAN in Slovak adolescents with T1D.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021798     DOI: 10.1016/j.jdiacomp.2012.07.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  Investigation of biomarker in laryngeal carcinomas.

Authors:  Deniz Kanliada; Ender Coskunpinar; Kadir Serkan Orhan; Yasemin Musteri Oltulu; Mehmet Celik; Ayse Eren; Ilhan Yaylim; Kemal Deger
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

2.  Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk.

Authors:  Adina Stoian; Claudia Bănescu; Rodica Ioana Bălaşa; Anca Moţăţăianu; Mircea Stoian; Valeriu G Moldovan; Septimiu Voidăzan; Minodora Dobreanu
Journal:  Dis Markers       Date:  2015-09-08       Impact factor: 3.434

3.  Genetics of diabetic neuropathy: Systematic review, meta-analysis and trial sequential analysis.

Authors:  Yating Zhao; Ruixia Zhu; Danni Wang; Xu Liu
Journal:  Ann Clin Transl Neurol       Date:  2019-09-26       Impact factor: 4.511

4.  The Role Of Adiponectin, TNF-α And Glutathione In The Pathogenesis And Evolution Of Type 1 Diabetes.

Authors:  Csilla Enikő Szabo; Roxana Flavia Ilieș; Casian Simon Aioanei; Andreea Catana; Victoria Creț; Radu Sorin Șerban; Ioan Victor Pop
Journal:  Diabetes Metab Syndr Obes       Date:  2019-11-05       Impact factor: 3.168

5.  Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy.

Authors:  Alamdar Dadbinpour; Mohammad Hasan Sheikhha; Mojtaba Darbouy; Mohammad Afkhami-Ardekani
Journal:  J Diabetes Metab Disord       Date:  2013-12-19

6.  Relationship of Podoplanin and Glutathione S-transferases T1 Expression with Laryngeal Cancer.

Authors:  Deniz Kanliada; Ender Coskunpinar; Kadir Serkan Orhan; Yasemin Musteri Oltulu; Mehmet Celik; Ayse Eren; Ilhan Yaylim; Kemal Deger
Journal:  Int J Mol Cell Med       Date:  2012

7.  Genetic polymorphisms of glutathione-s-transferase M1 and T1 genes with risk of diabetic retinopathy in Iranian population.

Authors:  Elham Moasser; Negar Azarpira; Babak Shirazi; Mostafa Saadat; Bita Geramizadeh
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.